JAMA Oncology (@jamaonc) 's Twitter Profile
JAMA Oncology

@jamaonc

JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

ID: 2811548749

linkhttp://ja.ma/tjamaoncology calendar_today15-09-2014 15:33:04

18,18K Tweet

47,47K Followers

513 Following

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

A 70-year-old man with a history of hypertension and chronic migraine presented with 10 months of progressive generalized muscle weakness and stiffness. Take the Clinical Challenge. ja.ma/3Srpib4

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Most viewed this week from JAMA Oncology: Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical trials, underscoring the need to critically evaluate Kaplan-Meier curves alongside hazard ratios. ja.ma/45zBluy

Most viewed this week from <a href="/JAMAOnc/">JAMA Oncology</a>: 

Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical trials, underscoring the need to critically evaluate Kaplan-Meier curves alongside hazard ratios. 

ja.ma/45zBluy
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Revised reference intervals for serum free light chains reduced false-positive rates for LC-MGUS diagnosis by 82%. ja.ma/4dy3NPo

Revised reference intervals for serum free light chains reduced false-positive rates for LC-MGUS diagnosis by 82%. ja.ma/4dy3NPo
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

JAMA Oncology is now on Bluesky! 🦋 Follow us there for the latest original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. ➡️ ja.ma/43WqKIP

JAMA Oncology is now on Bluesky! 🦋 

Follow us there for the latest original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.

➡️  ja.ma/43WqKIP
James Wu | 吴简凡 MD (@jamesfanwu) 's Twitter Profile Photo

Some of the best parts of #ASCO25 is the opportunity to meet in person your research collaborators from around the world!! Check one of our groups’ most recent publications on “National Cancer System Characteristics and Global Pan-Cancer Outcomes: jamanetwork.com/journals/jamao…

Some of the best parts of #ASCO25 is the opportunity to meet in person your research collaborators from around the world!! 

Check one of our groups’ most recent publications on “National Cancer System Characteristics and Global Pan-Cancer Outcomes: jamanetwork.com/journals/jamao…
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

📢 Calling all #ASCO25 attendees! Stay up to date with everything JAMA Oncology—follow us on Bluesky. ➡️ ja.ma/3ZIUrKY

📢 Calling all #ASCO25 attendees!

Stay up to date with everything JAMA Oncology—follow us on Bluesky. 

➡️ ja.ma/3ZIUrKY
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Interval breast cancer (IntCa) rates remain high despite mammographic screening, highlighting the need for personalized screening based on risk factors like high breast density, hormone replacement therapy, and family history. ja.ma/4jHqZfO

Interval breast cancer (IntCa) rates remain high despite mammographic screening, highlighting the need for personalized screening based on risk factors like high breast density, hormone replacement therapy, and family history. ja.ma/4jHqZfO
JAMA (@jama_current) 's Twitter Profile Photo

A cell-free DNA blood test could be an option for patients who repeatedly decline colonoscopy or stool testing for #ColorectalCancer screening. #ASCO25 Read the new JAMA Original Investigation to learn more. ja.ma/3FC1wWU

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

A study of 1.6 million US cancer patients in 2023 found 47.3% had a smoking history, with 14.7% currently smoking at diagnosis. ja.ma/43ErxwM

A study of 1.6 million US cancer patients in 2023 found 47.3% had a smoking history, with 14.7% currently smoking at diagnosis. ja.ma/43ErxwM
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. ja.ma/4jxfdEA

For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. ja.ma/4jxfdEA
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Survivors of childhood cancer undergo considerable accelerated aging in terms of early onset and excess risk of chronic health conditions. ja.ma/4kV9dqo

Survivors of childhood cancer undergo considerable accelerated aging in terms of early onset and excess risk of chronic health conditions. 

ja.ma/4kV9dqo
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

In childhood cancer survivors, obesity was linked to a higher risk of various subsequent neoplasm types, while increased physical activity was associated with a reduced risk. ja.ma/4dLqDTQ

In childhood cancer survivors, obesity was linked to a higher risk of various subsequent neoplasm types, while increased physical activity was associated with a reduced risk.

ja.ma/4dLqDTQ
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4jyRiED

Most viewed this week from <a href="/JAMAOnc/">JAMA Oncology</a>: 

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon.  

ja.ma/4jyRiED
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Approximately one-third of patients treated on TT 2 protocol and half of those treated on TT 3A protocol were alive at 15 to 20 years post-diagnosis. ja.ma/43uAn1m

Approximately one-third of patients treated on TT 2 protocol and half of those treated on TT 3A protocol were alive at 15 to 20 years post-diagnosis.

ja.ma/43uAn1m
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

From JAMA Internal Medicine: Mailed self-collection was effective for increasing #CervicalCancer screening participation among never- and under-screened women in a safety net health setting. ja.ma/442jwTH

From <a href="/JAMAInternalMed/">JAMA Internal Medicine</a>: Mailed self-collection was effective for increasing #CervicalCancer screening participation among never- and under-screened women in a safety net health setting.

ja.ma/442jwTH
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Viewpoint: As palliative care clinicians, we urge the adoption of buprenorphine as a first-line opioid for cancer pain due to its effectiveness and safety profile. ja.ma/45bAgsQ

Viewpoint: As palliative care clinicians, we urge the adoption of buprenorphine as a first-line opioid for cancer pain due to its effectiveness and safety profile.

ja.ma/45bAgsQ
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4dVJAU8

Most viewed this week from <a href="/JAMAOnc/">JAMA Oncology</a>: 

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon.  

ja.ma/4dVJAU8
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Initiating fecal immunochemical test screening for colorectal cancer at ages 40 to 49 leads to reductions in colorectal cancer mortality and incidence. ja.ma/45mHxGm

Initiating fecal immunochemical test screening for colorectal cancer at ages 40 to 49 leads to reductions in colorectal cancer mortality and incidence. ja.ma/45mHxGm
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Cancer rates among people with HIV have declined for certain types, like non-Hodgkin lymphoma and Kaposi sarcoma, due to improved HIV care, though the risk for other cancers remains largely unchanged. ja.ma/4nhUmZ9

Cancer rates among people with HIV have declined for certain types, like non-Hodgkin lymphoma and Kaposi sarcoma, due to improved HIV care, though the risk for other cancers remains largely unchanged. ja.ma/4nhUmZ9
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

"Caring for fasting oncology patients during Ramadan requires a thoughtful, individualized approach." This Viewpoint discusses how oncology clinicians can provide culturally sensitive care for Muslim cancer patients fasting during Ramadan. ja.ma/3HGG7fP

"Caring for fasting oncology patients during Ramadan requires a thoughtful, individualized approach." 

This Viewpoint discusses how oncology clinicians can provide culturally sensitive care for Muslim cancer patients fasting during Ramadan.

ja.ma/3HGG7fP